BIOVITRUM
Biovitrum is an international pharmaceutical company that markets specialist pharmaceuticals in several regions globally. Using its expertise and experience Biovitrum takes scientific innovation to patients with significant unmet medical need. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within our prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company has revenues of approximately SEK 1.2 billion and around 400 employees. The company head office is located in Sweden. In 2009, Biovitrum merged with [Swedish Orphan](/organization/swedish-orphan), and the combined company has subsequently been rebranded as Swedish Orphan Biovitrum.
BIOVITRUM
Industry:
Biotechnology Health Care
Founded:
2001-01-01
Address:
Stockholm, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.biovitrum.com
Total Employee:
501+
Status:
Active
Contact:
46 86 97 20 00
Total Funding:
0
Technology used in webpage:
SPF Domain Not Resolving Microsoft DMARC Microsoft Azure Barracuda Networks Akamai Hosted Microsoft Azure Europe North Region
Similar Organizations
Merck
Merck is a pharmaceutical and chemical enterprise that develops prescription drugs and over-the-counter products.
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2005-08-22 | Arexis AB | Arexis AB acquired by Biovitrum | N/A |
| 2005-03-21 | Cambridge Biotechnology | Cambridge Biotechnology acquired by Biovitrum | N/A |
Investors List
Alta Partners
Alta Partners investment in Venture Round - Biovitrum
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Venture Round - Biovitrum
More informations about "Biovitrum"
Biovitrum: New organisation in Biovitrum | Sobi
Dec 1, 2006 Biovitrum develops and produces protein-based drugs on a contractual basis and markets a range of specialist pharmaceuticals primarily in the Nordic countries. Biovitrum has …See details»
Biovitrum - Crunchbase Company Profile & Funding
Biovitrum is an international pharmaceutical company that markets specialist pharmaceuticals in several regions globally. Using its expertise and experience Biovitrum takes scientific innovation to patients with significant unmet medical …See details»
Swedish Orphan Biovitrum - Crunchbase Company …
Swedish Orphan Biovitrum engages in the development, marketing, and distribution of orphan products and specialty pharmaceuticals. It offers drugs for the treatment of rare and life-threatening diseases, such as cardiology, …See details»
Sobi - Swedish Orphan Biovitrum AB (publ) - LinkedIn
Sobi - Swedish Orphan Biovitrum AB (publ) | 76,067 followers on LinkedIn. rare strength | Sobi is a specialised international biopharmaceutical company transforming the lives of people with rare ...See details»
Biovitrum AB - Stockholm, Sweden - bionity.com
Jan 26, 2010 Biovitrum is one of the largest biopharma companies in Europe. With operations in Sweden and in the UK Biovitrum conducts research and develops pharmaceuticals for unmet …See details»
Biovitrum Implements Strategic Restructuring of the R&D …
Biovitrum AB (publ) Erik Kinnman, Vice President Investor Relations Phone: +46 73 422 15 40 [email protected] Martin Nicklasson, CEO Phone. +46 8 697 20 00 …See details»
Biovitrum Company Profile 2024: Valuation, Investors ... - PitchBook
Biovitrum was founded in 2001. Where is Biovitrum headquartered? Biovitrum is headquartered in Stockholm, Sweden. What is the size of Biovitrum? Biovitrum has 547 total employees. What …See details»
Swedish Orphan Biovitrum AB - AnnualReports.com
Swedish Orphan Biovitrum AB reports have an aggregate usefulness score of 4.7 based on 52 reviews. Swedish Orphan Biovitrum AB. Most Recent Annual Report. MOST RECENT 2023 Annual Report. View PDF. View 2023 …See details»
BioVitrum (EN) - 2001. What was "BioVitrum" at the... - Facebook
Jul 9, 2021 2001. What was "BioVitrum" at the beginning? Today it’s impossible to imagine a business organization without start-up capital or the shadow of a large investor over it. In 2001, BioVitrum began to...See details»
Biovitrum - Crunchbase
Biovitrum is an international pharmaceutical company that markets specialist pharmaceuticals in several regions globally.See details»
BioVitrum - Crunchbase Company Profile & Funding
Organization. BioVitrum . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. BioVitrum is a manufacturer of diagnostic equipment and …See details»
Annual and Sustainability Report 2020 - Sobi
Apr 6, 2021 Sobi™ publishes 2020 Annual and Sustainability Report. Swedish Orphan Biovitrum AB (publ) (Sobi™) has released the company's 2020 Annual and Sustainability Report. The …See details»
Biovitrum Implements Strategic Restructuring of the R&D …
May 15, 2008 Running R&D expenses estimated to be reduced by MSEK 115 on a rolling twelve-month basis STOCKHOLM, May 15, 2008. The Swedish pharmaceutical company …See details»
Company profile - BioVitrum
The production of the BioVitrum group of companies was founded in 2001 in St. Petersburg.Today it includes: the production of reagents and consumables for histological sample preparation, …See details»
BioVitrum`s history
А new partner - BioVitrum is the official distributor of TriFoil Imaging company in Russia and Kazakhstan. Became a distributor of Bio-Rad products in Life Science Research. BioVitrum is …See details»
BioVitrum
Компания БиоВитрум - является одним из лидеров в производстве и поставках ...See details»
U.S. Private Equity Finds Neat $8 Billion Biotech in Sweden
Sep 2, 2021 Swedish Orphan Biovitrum AB, a biotech specializing in rare diseases with a focus on haematology and immunology, agreed on Thursday to be bought by the consortium for 69 …See details»
Biovitrum AB
了解Biovitrum AB (Biovitrum AB)公司的药物管线，治疗领域，技术平台，以及它的7项临床试验, 64篇新闻和3篇文献，疾病领域:血液及淋巴系统疾病，免疫系统疾病，肿瘤，神经系统疾病，内分泌与代谢疾病，感染，技术平台:小分子化药，白细胞介素，合成多肽，单克隆抗体，药物:尼替西农，安纳白介素 ...See details»
WHO IS BIOVITRUM?
The BioVitrum company has been operating in the Russian market of medical and laboratory equipment since 2001. Over the years of active work, the company has become a …See details»